Hepion Pharmaceuticals, Inc. (HEPA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.06
Day's range
$0.07

Hepion Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 07/14/2023 3.31 M $2.57 M   0.00% 4.34%
BLACKROCK INC. 05/12/2023 1.60 M $1.24 M   0.33% 2.10%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2023 656.45 K $509.74 K   0.00% 0.86%
STATE STREET CORP 05/15/2023 313.50 K $243.43 K   0.00% 0.41%
RENAISSANCE TECHNOLOGIES LLC 05/12/2023 284.30 K $221.00 K   15.76% 0.37%
ENVESTNET ASSET MANAGEMENT INC 05/11/2023 156.91 K $121.84 K   -22.70% 0.21%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/16/2023 154.75 K $120.17 K   61.32% 0.20%
NORTHERN TRUST CORP 05/15/2023 132.06 K $102.54 K   0.00% 0.17%
BANK OF NEW YORK MELLON CORP 05/09/2023 88.72 K $68.89 K   0.00% 0.12%
MORGAN STANLEY 05/15/2023 88.22 K $68.50 K   9.72% 0.12%
MCADAM, LLC 04/24/2023 62.17 K $48.27 K   0.00% 0.08%
PNC FINANCIAL SERVICES GROUP, INC. 05/15/2023 57.53 K $44.65 K   -0.10% 0.08%
VIRTU FINANCIAL LLC 05/01/2023 53.50 K $42.00 K   152.78% 0.07%
ADVISOR GROUP HOLDINGS, INC. 05/12/2023 47.52 K $36.90 K   41.02% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/16/2023 37.00 K $28.86 K   -35.20% 0.05%
CITADEL ADVISORS LLC 05/15/2023 34.80 K $27.02 K   14.10% 0.05%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/12/2023 31.54 K $24.49 K   0.00% 0.04%
TWO SIGMA ADVISERS, LP 05/15/2023 25.90 K $20.11 K   0.00% 0.03%
CETERA INVESTMENT ADVISERS 05/15/2023 19.75 K $15.33 K   -33.59% 0.03%
UBS GROUP AG 05/12/2023 14.07 K $10.92 K   100.00% 0.02%
AMUSSEN HUNSAKER ASSOCIATES LLC 05/15/2023 13.31 K $10.33 K   100.00% 0.02%
GROUP ONE TRADING, L.P. 05/12/2023 13.13 K $10.19 K   -46.06% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 05/09/2023 10.56 K $8.00 K   -67.28% 0.01%
AMPLIUS WEALTH ADVISORS, LLC 04/25/2023 10.00 K $7.77 K   0.00% 0.01%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 08/15/2024 3.50 K $2.72 K   0.00% 0.00%
CITADEL ADVISORS LLC 05/15/2023 1.65 K $1.28 K   -61.54% 0.00%
WELLS FARGO & COMPANY/MN 05/12/2023 528 $410   1.73% 0.00%
BARCLAYS PLC 05/04/2023 309 $0   0.00% 0.00%
SIGNATUREFD, LLC 04/28/2023 2 $2   0.00% 0.00%
HARBOR INVESTMENT ADVISORY, LLC 04/21/2023 1 $1   100.00% 0.00%
ALLWORTH FINANCIAL LP 04/18/2023 1 $1   100.00% 0.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 04/27/2023 1 $0   -99.90% 0.00%
CAPITAL ADVISORS, LTD. LLC 05/03/2023 1 $0   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/12/2023 0 $0   -100.00% 0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 05/15/2023 0 $0   0.00% 0.00%
PVG ASSET MANAGEMENT CORP 07/24/2023 0 $0   -100.00% 0.00%
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. 04/14/2023 0 $0   -100.00% 0.00%
IFP ADVISORS, INC 04/18/2023 0 $0   -100.00% 0.00%

Hepion Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 3 institutional investors and hedge funds held shares of Hepion Pharmaceuticals, Inc.. The most heavily invested institutionals were:

SAN FRANCISCO SENTRY INVESTMENT GROUP (CA): 10,000

LADENBURG THALMANN FINANCIAL SERVICES INC.: 47

Advisor Group, Inc.: 1

9.38% of Hepion Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 10.05 K shares in the last 24 months. This purchase volume represents approximately $703 in transactions.